Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Br J Cancer · 2017 · PMC5729470 · PMID 29024937

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a trend towards significanceP =0.06so close (0.05 < p ≤ 0.1)

In addition, several proteins show a trend towards significance: higher levels of phospho-EGFR ( P =0.06), FGFR4 ( P =0.06), phospho-GSK3 ( P =0.07) and p53 ( P =0.07) are associated with a better response to treatment ( Figure 2 ).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.